Bing Qi

944 total citations
56 papers, 685 citations indexed

About

Bing Qi is a scholar working on Oncology, Molecular Biology and Physiology. According to data from OpenAlex, Bing Qi has authored 56 papers receiving a total of 685 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 15 papers in Molecular Biology and 10 papers in Physiology. Recurrent topics in Bing Qi's work include Drug Transport and Resistance Mechanisms (8 papers), Pancreatitis Pathology and Treatment (6 papers) and Pharmacological Effects and Toxicity Studies (6 papers). Bing Qi is often cited by papers focused on Drug Transport and Resistance Mechanisms (8 papers), Pancreatitis Pathology and Treatment (6 papers) and Pharmacological Effects and Toxicity Studies (6 papers). Bing Qi collaborates with scholars based in China, Belgium and Japan. Bing Qi's co-authors include Hai–Ling Qiao, Yan Fang, Na Gao, Lin-Jing Jia, Hiroshi Sugiya, Pieter Annaert, Dong Shang, Junko Fujita‐Yoshigaki, Takanori Narita and Qingkai Zhang and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Scientific Reports.

In The Last Decade

Bing Qi

55 papers receiving 680 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bing Qi China 16 257 136 131 104 78 56 685
Ruolan Dong China 17 276 1.1× 68 0.5× 80 0.6× 64 0.6× 61 0.8× 30 697
Ko‐Chao Lee Taiwan 19 367 1.4× 131 1.0× 190 1.5× 117 1.1× 224 2.9× 54 886
Carla J. Gallagher United States 18 388 1.5× 196 1.4× 130 1.0× 62 0.6× 44 0.6× 32 834
Joe Palandra United States 15 282 1.1× 136 1.0× 360 2.7× 87 0.8× 73 0.9× 25 838
Weijian Zhang China 16 350 1.4× 70 0.5× 106 0.8× 85 0.8× 52 0.7× 52 1.0k
Amro El‐Karef Egypt 16 236 0.9× 164 1.2× 71 0.5× 53 0.5× 62 0.8× 24 681
Honghong Liu China 18 464 1.8× 230 1.7× 91 0.7× 119 1.1× 108 1.4× 60 964
Mingrui Xiong China 17 361 1.4× 38 0.3× 78 0.6× 128 1.2× 65 0.8× 28 891
Makoto Hayakari Japan 16 465 1.8× 92 0.7× 126 1.0× 64 0.6× 54 0.7× 58 878

Countries citing papers authored by Bing Qi

Since Specialization
Citations

This map shows the geographic impact of Bing Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing Qi more than expected).

Fields of papers citing papers by Bing Qi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bing Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing Qi. The network helps show where Bing Qi may publish in the future.

Co-authorship network of co-authors of Bing Qi

This figure shows the co-authorship network connecting the top 25 collaborators of Bing Qi. A scholar is included among the top collaborators of Bing Qi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bing Qi. Bing Qi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Meng, Tingting, Peng Ma, Shuxin Chen, et al.. (2025). Microemulsion-based drug delivery system identifies pepper alkaloids as anti-obesity compounds. Acta Pharmacologica Sinica. 46(8). 2310–2322. 1 indexed citations
2.
Wu, Mengyao, Le Yang, Yufei Zhai, et al.. (2025). A novel compound DBZ alleviates chronic inflammatory pain and anxiety-like behaviors by targeting the JAK2-STAT3 signaling pathway. Journal of Biological Chemistry. 301(7). 110223–110223. 1 indexed citations
3.
Qi, Bing, et al.. (2023). Unravelling the Hepatic Elimination Mechanisms of Colistin. Pharmaceutical Research. 40(7). 1723–1734. 1 indexed citations
4.
Zhang, Haoxiang, Jiangping Gao, Zhen Sun, et al.. (2023). Diagnostic accuracy of updated risk assessment criteria and development of novel computational prediction models for patients with suspected choledocholithiasis. Surgical Endoscopy. 37(9). 7348–7357. 6 indexed citations
5.
Wang, Quanquan, et al.. (2022). The Clinical, Myopathological, and Genetic Analysis of 20 Patients With Non-dystrophic Myotonia. Frontiers in Neurology. 13. 830707–830707. 6 indexed citations
6.
Guo, Xuan, et al.. (2022). Gene analysis and clinical features of 22 GNE myopathy patients. Neurological Sciences. 43(8). 5049–5056. 5 indexed citations
7.
Jiao, Juying, Jianjun Liu, Qi Li, et al.. (2022). Gut Microbiota-Derived Diaminopimelic Acid Promotes the NOD1/RIP2 Signaling Pathway and Plays a Key Role in the Progression of Severe Acute Pancreatitis. Frontiers in Cellular and Infection Microbiology. 12. 838340–838340. 11 indexed citations
8.
Buyck, Christophe, Bing Qi, Herman van Vlijmen, et al.. (2021). Identification of novel inhibitors of rat Mrp3. European Journal of Pharmaceutical Sciences. 162. 105813–105813. 2 indexed citations
9.
10.
Qi, Bing, et al.. (2019). A sensitive liquid chromatography method for analysis of propofol in small volumes of neonatal blood. Journal of Clinical Pharmacy and Therapeutics. 45(1). 128–133. 5 indexed citations
11.
Qi, Bing, Eva Gijbels, Mathieu Vinken, et al.. (2019). Current insights in the complexities underlying drug-induced cholestasis. Critical Reviews in Toxicology. 49(6). 520–548. 20 indexed citations
12.
Qi, Bing, et al.. (2019). Transplacental transport of paracetamol and its phase II metabolites using the ex vivo placenta perfusion model. Toxicology and Applied Pharmacology. 370. 14–23. 22 indexed citations
13.
Gao, Na, Jing Li, Bing Qi, et al.. (2018). Higher Activity of Alcohol Dehydrogenase Is Correlated with Hepatic Fibrogenesis. Journal of Pharmacology and Experimental Therapeutics. 367(3). 473–482. 13 indexed citations
14.
Wang, Guifang, et al.. (2017). The association of lumican polymorphisms and high myopia in a Southern Chinese population. International Journal of Ophthalmology. 10(10). 1516–1520. 8 indexed citations
15.
Nicolaï, Johan, Bing Qi, Bruno Stieger, et al.. (2017). Role of the OATP Transporter Family and a Benzbromarone-SensitiveEfflux Transporter in the Hepatocellular Disposition of Vincristine. Pharmaceutical Research. 34(11). 2336–2348. 8 indexed citations
16.
Xiang, Hong, Guijun Wang, Jialin Qu, et al.. (2016). Yin-Chen-Hao Tang Attenuates Severe Acute Pancreatitis in Rat: An Experimental Verification of In silico Network Target Prediction. Frontiers in Pharmacology. 7. 1203–1203. 18 indexed citations
17.
Zhang, Haifeng, Na Gao, Xin Tian, et al.. (2015). Content and activity of human liver microsomal protein and prediction of individual hepatic clearance in vivo. Scientific Reports. 5(1). 17671–17671. 85 indexed citations
18.
19.
Qi, Bing. (2005). A Study on the Parameters of CT Pulmonary Function Imaging of Normal Control Group.
20.
Qi, Bing, et al.. (2003). Analysis of gene expression in rabbit nuclear transfer embryos: Use of single‐embryo mRNA differential display. Development Growth & Differentiation. 45(5-6). 543–552. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ruolan Dong Breakdown of academic impact, for papers by Ko‐Chao Lee Breakdown of academic impact, for papers by Carla J. Gallagher Breakdown of academic impact, for papers by Joe Palandra Breakdown of academic impact, for papers by Weijian Zhang Breakdown of academic impact, for papers by Amro El‐Karef Breakdown of academic impact, for papers by Honghong Liu Breakdown of academic impact, for papers by Mingrui Xiong Breakdown of academic impact, for papers by Makoto Hayakari
Rankless by CCL
2026